Corebridge Financial’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,544
| Closed | -$40.1K | – | 1578 |
|
|
2025
Q1 | $40.1K | Sell |
11,544
-171
| -1% | -$593 | ﹤0.01% | 2786 |
|
|
2024
Q4 | $77.1K | Sell |
11,715
-885
| -7% | -$5.82K | ﹤0.01% | 2673 |
|
|
2024
Q3 | $114K | Buy |
12,600
+7,093
| +129% | +$64.1K | ﹤0.01% | 2553 |
|
|
2024
Q2 | $88.3K | Buy |
+5,507
| New | +$88.3K | ﹤0.01% | 2660 |
|